Overview

Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions

Status:
Completed
Trial end date:
2018-12-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the release of memantine into the bloodstream of two different formulations: one formulation containing lactose and one without lactose.
Phase:
Phase 1
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Memantine